SNAQ Launches AI-Powered Glucose Prediction feature

SNAQ Launches AI-Powered Glucose Prediction feature

SNAQ Launches AI-Powered Glucose Prediction feature

SNAQ has introduced a groundbreaking AI-driven feature that predicts glucose responses before meals, revolutionizing diabetes care.

The new meal glucose prediction tool allows CGM users to anticipate their body’s reaction to food using a proprietary deep learning model and a unique digital twin approach. This innovation offers highly personalized insights for improved glucose control.

SNAQ also secured new funding led by the Diabetes Venture Fund at Serpentine Ventures, reinforcing investor confidence despite a tough market. CEO Aurelian Briner emphasized the company’s commitment to scaling innovations and transforming diabetes care. Looking ahead, SNAQ plans to introduce more AI-driven advancements to empower individuals in managing their health.

For more details, read the full press release or visit SNAQ’s website to learn more about their innovations in diabetes care.

More recent news

Meet us at ATTD!

Meet us at ATTD!

The ATTD congress in Amsterdam is just around the corner and different members of the DCB team will be on-site. Meet...

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

DCB featured in Finanz und Wirtschaft – Health & Wealth 3/2025

DCB featured in Finanz und Wirtschaft – Health & Wealth 3/2025

DCB featured in Finanz und Wirtschaft – Health & Wealth 3/2025

Discover how DCB leads the way in diabetes technology through its innovative collaborations and community-focused research, as featured in the special issue of Finanz und Wirtschaft.

DCB in Finanz und Wirtschaft special

A unique aspect of DCB is its close collaboration with the diabetes community, integrating their needs and experiences into research and development processes. DCB also partners with international research and industry organizations to enhance healthcare efficiency and improve the quality of life for people with diabetes.

On the right, you can download the entire article in German.

More recent news

Meet us at ATTD!

Meet us at ATTD!

The ATTD congress in Amsterdam is just around the corner and different members of the DCB team will be on-site. Meet...

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

Meet us at ATTD!

Meet us at ATTD!

Meet us at ATTD!

The ATTD congress in Amsterdam is just around the corner and different members of the DCB team will be on-site. Meet us there to discuss our services, potential collaborations or just chat over a coffee!

DCB at ATTD 2025

The ATTD (Advanced Technologies & Treatments in Diabetes) congress is the leading international meeting point for all those involved and interested in diabetes technology. DCB is thrilled to participate in this prestigious event in Amsterdam fostering connections with like-minded enthusiasts dedicated to diabetes technology, innovation, and research.

We will be present with different members of our team from different divisions. Additionally, members of our Lived Experience Panel will also be attending. We are looking forward to attending insightful Scientific sessions, exploring new innovative solutions and above all: networking with, you!

Also, we are excited to participate in ATTD Ignite 2025, an exclusive platform designed to foster innovation and collaboration in diabetes technology. This event, taking place on March 19, 2025, from 09:00 to 13:00 in Hall C, provides a unique opportunity for startups and researchers to connect, share insights, and accelerate breakthroughs in diabetes care. Greta Ehlers, Business Scouting & Development at DCB, will be speaking in the session “Empowering Startups for Success” from 09:05 to 10:00, where key topics such as funding strategies, pitch refinement, and global expansion will be discussed. Don’t miss this opportunity to gain valuable insights and engage with industry experts!

If you are attending ATTD and are eager to learn more about our services, the Open Innovation Challenge, our main research areas, our community, or any other topics – please reach out to those attending and book a coffee slot. We look forward to connecting with you!

Unable to attend ATTD but curious about our services and activities? We would also be happy to schedule calls for after the conference to discuss potential collaborations. Feel free to reach out to individual members of our team.

Downloads

Book a coffee with us!

Hanne Ballhausen

Project Manager Innovation

Book a Coffee Slot

Dr. Maren Schinz

Project Lead Insulin Activity

Book a Coffee Slot

Greta Ehlers

Business Development

Send an E-Mail

More recent news

Meet us at ATTD!

Meet us at ATTD!

The ATTD congress in Amsterdam is just around the corner and different members of the DCB team will be on-site. Meet...

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

DCB featured in Sonntagszeitung – Gesundheitsguide 12/2024

DCB featured in Sonntagszeitung – Gesundheitsguide 12/2024

DCB featured in Sonntagszeitung – Gesundheitsguide 12/2024

Dive into the latest edition of Sonntagszeitung Gesundheitsguide and find out why DCB is global leader in diabetes technology.

DCB innovative Technologies highlighted in latest Sonntagszeitung edition

Our DCB Start-up Night and especially this years winner “IMS” were featured in this publication.

IMS was able to persuade our expert jury with an revolutionary device for glucose measurement. The Start-up Beep Insights was awarded a Public Choice Award for their Beep-App helping to estimate insulin resistance.
We are also supporting Inhouse-Projects like for example Beyond Diagnostics that aims to improve the safety of therapy for people with diabetes. 

Do you have an idea in the are of diabetes technology? Feel free to contact us

For more details, explore the latest below embedded edition Sonntagszeitung 12 / 2024.

The full article is available in German.

More recent news

Meet us at ATTD!

Meet us at ATTD!

The ATTD congress in Amsterdam is just around the corner and different members of the DCB team will be on-site. Meet...

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

Optimize your mealtimes with SNAQ – smarter glucose management

Optimize your mealtimes with SNAQ – smarter glucose management

Optimize your mealtimes with SNAQ – smarter glucose management

Unlock new insights with SNAQ – now with 40% off!
SNAQ: Smarter glucose management for mealtimes

We’re excited to introduce SNAQ, an app designed to help people with diabetes better understand and manage their glucose levels during meals. With its seamless meal tracking and real-time data integration, SNAQ transforms how you approach glucose management. SNAQ empowers users to make informed decisions by providing insights into how food choices impact blood sugar levels.

Key features:

  • Photo-based meal tracking: Snap a picture of your meal to analyze its nutritional impact.
  • Seamless data integration: Sync meals with your glucose and activity data automatically.
  • Insights for better choices: Understand how different foods affect your blood sugar.
  • Learn from patterns: Use past meals to make informed decisions for the future.

SNAQ simplifies meal tracking, making it easier than ever to optimize glucose management during meals.

This special offer, including 40% off, is available now via a unique link (redeem using your mobile device): https://snaq.page.link/season-special

Valid from December 16 to January 31 – exclusively for iOS and Android users! 

More recent news

Meet us at ATTD!

Meet us at ATTD!

The ATTD congress in Amsterdam is just around the corner and different members of the DCB team will be on-site. Meet...

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

Enhance-d: Improving Diabetes Self-Management with AI and Real-Time Data

Enhance-d: Improving Diabetes Self-Management with AI and Real-Time Data

Enhance-d: Improving Diabetes Self-Management with AI and Real-Time Data

Now Available: Manage Your Diabetes with Enhance-d, Supported by DCB

Enhance-d: Diabetes Self-Management

We’re excited to announce that Enhance-d is now available! This innovative app empowers people with diabetes to better understand and manage their health. With real-time diagnostics, AI-powered analytics, and intuitive visualizations, Enhance-d transforms complex diabetes data into clear, actionable insights. Whether you’re organizing your daily routine or optimizing performance as an athlete, Enhance-d provides the tools you need to manage your diabetes self-management.

Key Features Include:

  • Real-Time Monitoring: Stay updated with live glucose data
  • AI-Driven Insights: Get personalized recommendations tailored to your needs
  • Clear Visualizations: Easily understand the impact of nutrition, exercise and other factors
  • Custom Alerts: Stay proactive with timely notifications

Now available on iOS and Android, Enhance-d connects seamlessly with CGMs, insulin delivery devices, wearables, and lifestyle apps to give you a complete picture of your health.

Learn more about the project and our collaboration here: https://www.dcberne.com/en/project/enhance-d-enhanced-diabetes-self-management/

More recent news

Meet us at ATTD!

Meet us at ATTD!

The ATTD congress in Amsterdam is just around the corner and different members of the DCB team will be on-site. Meet...

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland